Clinical Trial

Evaluation of Implantoplasty in the Treatment of Peri-Implantitis.

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this longitudinal study is to evaluate the clinical impact of implantoplasty in the treatment of peri-implantitis, exploring the potential effect of removing compromised implants on periodontal health and its correlation with the presence of titanium particles in the crevicular fluid. In addition, we seek to investigate changes in the peri-implant microbiological profile before and after implantoplasty, allowing a more comprehensive understanding of the effects of this procedure at both the biological and clinical levels, considering microbiological factors and the relationship with titanium, inflammation and peri-implant health. Forty participants diagnosed with peri-implantitis will be selected (n = 20 in each group) to participate in the study. They will be randomly allocated into two groups, according to the treatment to be performed (implantoplasty group and surgical access group for scaling). Using a millimeter-diameter periodontal probe, the initial clinical parameters of patients with periodontal and peri-implant disease will be evaluated. Biofilm and crevicular fluid will then be collected using sterile paper cones from one implant of each patient in all groups at follow-up intervals of 1, 3 and 6 months for subsequent processing and evaluation of the data. The integration of these analyses aims to offer valuable insights to optimize peri-implantitis treatment strategies, aiming at the health and longevity of dental implants.
Protocol Amendment History 1 change
minor Completion pushed: 2026-07-01 -> 2026-09-01 2026-08-05
Trial Details
NCT Number NCT06884475
Lead Sponsor University of Campinas, Brazil
Conditions Peri-Implantitis and Peri-implant Mucositis
Enrollment 40 participants
Start Date 2025-04-01
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-04